Regeneron Pharmaceuticals (REGN) Shares Outstanding (2009 - 2026)

Regeneron Pharmaceuticals' Shares Outstanding history runs 18 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding changed 0.0% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (changed 0.0% YoY), while the FY2025 annual figure was $1.8 million, down 98.68% from the prior year.
• Shares Outstanding was $1.8 million for Q1 2026 at Regeneron Pharmaceuticals, roughly flat from $1.8 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $136.1 million in Q1 2025 to a low of $1.8 million in Q2 2022.
• Historically, Shares Outstanding has averaged $63.3 million across 5 years, with a median of $1.8 million in 2022.
• Biggest YoY gain for Shares Outstanding was 7466.67% in 2025; the steepest drop was 98.68% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $1.8 million in 2022, then jumped by 7294.44% to $133.1 million in 2023, then grew by 2.18% to $136.0 million in 2024, then plunged by 98.68% to $1.8 million in 2025, then changed by 0.0% to $1.8 million in 2026.
• The last three Shares Outstanding figures came in at $1.8 million (Q1 2026), $1.8 million (Q4 2025), and $136.2 million (Q3 2025), per Business Quant data.